These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15577535)

  • 1. Barriers to participating in an HIV vaccine trial: a systematic review.
    Mills E; Cooper C; Guyatt G; Gilchrist A; Rachlis B; Sulway C; Wilson K
    AIDS; 2004 Nov; 18(17):2235-42. PubMed ID: 15577535
    [No Abstract]   [Full Text] [Related]  

  • 2. Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic.
    Barrington C; Moreno L; Kerrigan D
    AIDS Care; 2007 Aug; 19(7):871-7. PubMed ID: 17712690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
    Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
    AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical considerations in vaccine trials with special reference to candidate HIV vaccines.
    Fast PE; Sawyer LA; Wescott SL
    Pharm Biotechnol; 1995; 6():97-134. PubMed ID: 7551256
    [No Abstract]   [Full Text] [Related]  

  • 5. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
    Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
    AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.
    Lee SJ; Brooks RA; Newman PA; Seiden D; Sangthong R; Duan N
    AIDS Care; 2008 Nov; 20(10):1161-8. PubMed ID: 18608068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.
    Newman PA; Duan N; Lee SJ; Rudy ET; Seiden DS; Kakinami L; Cunningham WE
    Vaccine; 2006 Mar; 24(12):2094-101. PubMed ID: 16332402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community preparedness for HIV vaccine trials in the Democratic Republic of Congo.
    Olin J; Kokolamami J; Lepira FB; Mwandagalirwa K; Mupenda B; Ndongala ML; Maman S; Bollinger R; Nachega J; Mokili J
    Cult Health Sex; 2006; 8(6):529-44. PubMed ID: 17050384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV vaccine AIDSVAX.
    Drugs R D; 1999 Jun; 1(6):456-8. PubMed ID: 10566083
    [No Abstract]   [Full Text] [Related]  

  • 11. Searching for that ounce of prevention. Promising strategies for an AIDS vaccine.
    Fischer JS
    US News World Rep; 2000 Jul; 129(3):45-6. PubMed ID: 10977753
    [No Abstract]   [Full Text] [Related]  

  • 12. The serostatus approach to HIV prevention and care: cautions and caveats.
    Mills S
    Am J Public Health; 2002 Mar; 92(3):331-3. PubMed ID: 11867295
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine vCP205. ALVAC-HIV vCP205, ALVAC vCP205.
    Drugs R D; 1999 Jun; 1(6):459-60. PubMed ID: 10566084
    [No Abstract]   [Full Text] [Related]  

  • 14. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
    Balfour L; Corace K; Tasca GA; Tremblay C; Routy JP; Angel JB
    AIDS Care; 2010 Nov; 22(11):1403-9. PubMed ID: 20936540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV gp160 vaccine (Immuno AG).
    Drugs R D; 1999 Jun; 1(6):449-50. PubMed ID: 10566080
    [No Abstract]   [Full Text] [Related]  

  • 16. Health beliefs and intention to get immunized for HIV.
    Zimet GD; Liau A; Fortenberry VD
    J Adolesc Health; 1997 May; 20(5):354-9. PubMed ID: 9168382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV HGP-30W vaccine (Cel-Sci).
    Drugs R D; 1999 Jun; 1(6):453-5. PubMed ID: 10566082
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic.
    Barrington C; Moreno L; Kerrigan D
    Cult Health Sex; 2008 May; 10(4):391-401. PubMed ID: 18484381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to volunteer enrollment in HIV preventive vaccine clinical research trials: a review of the literature.
    Hurley-Rosenblatt A; Dorsen C
    J Assoc Nurses AIDS Care; 2011; 22(4):330-4. PubMed ID: 21256768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.